Allergic and immunologic disorders of the eye. Part II: ocular allergy

L Bielory - Journal of Allergy and Clinical Immunology, 2000 - Elsevier
Allergy affects more than 15% of the world population, and some studies have shown that up
30% of the US population has some form of allergy. Most of these patients have various …

Oral tolerance: therapeutic implications for autoimmune diseases

AMC Faria, HL Weiner - Journal of Immunology Research, 2006 - Wiley Online Library
Oral tolerance is classically defined as the suppression of immune responses to antigens
(Ag) that have been administered previously by the oral route. Multiple mechanisms of …

Acetylcholine receptors and myasthenia

JM Lindstrom - Muscle & Nerve: Official Journal of the …, 2000 - Wiley Online Library
Much progress has been made in the 26 years since initial studies of the first purified
acetylcholine receptors (AChRs) led to the discovery that an antibody‐mediated …

A clinical grading system for retinal inflammation in the chronic model of experimental autoimmune uveoretinitis using digital fundus images

H Xu, P Koch, M Chen, A Lau, DM Reid… - Experimental eye …, 2008 - Elsevier
Experimental autoimmune uveoretinitis (EAU), a widely used animal model of human
posterior/pan-uveitis, is extremely valuable in allowing understanding of the pathogenesis of …

Blocking the inflammasome: A novel approach to treat uveitis

A Shome, OO Mugisho, RL Niederer, ID Rupenthal - Drug Discovery Today, 2021 - Elsevier
Uveitis is a complex ocular inflammatory disease often accompanied by bacterial or viral
infections (infectious uveitis) or underlying autoimmune diseases (non-infectious uveitis) …

Inhibition of tumor necrosis factor activity minimizes target organ damage in experimental autoimmune uveoretinitis despite quantitatively normal activated T cell traffic …

AD Dick, PG McMenamin, H Körner… - European journal of …, 1996 - Wiley Online Library
Recent studies demonstrated that administration of a p55‐tumor necrosis factor (TNF)
receptor IgG‐fusion protein (TNFR‐IgG) prevented the clinical onset of experimental …

Marrow-derived activated macrophages are required during the effector phase of experimental autoimmune uveoretinitis in rats

JV Forrester, I Huitinga, L Lumsden… - Current eye …, 1998 - Taylor & Francis
Purpose. Experimental autoimmune uveoretinitis (EAU), an established model for human
endogenous (autoimmune) posterior uveitis, is a CD4+ T cell-mediated disease inducible in …

Treatment of experimental autoimmune uveoretinitis with poly (lactic acid) nanoparticles encapsulating betamethasone phosphate

T Sakai, H Kohno, T Ishihara, M Higaki, S Saito… - Experimental eye …, 2006 - Elsevier
We have developed nanoparticles (NPs), which are capable of targeting a specific lesion
and gradually releasing the agent at the site over a prolonged time period after a single …

Hierarchy in the ability of T cell epitopes to induce peripheral tolerance to antigens from myelin

SM Anderton, DC Wraith - European journal of immunology, 1998 - Wiley Online Library
Nasal administration of peptide antigens has been shown to induce T cell tolerance. We
have investigated the potential for peptide therapy of the autoimmune response to myelin …

Mucosal tolerance and suppression of collagen-induced arthritis (CIA) induced by nasal inhalation of synthetic peptide 184-198 of bovine type II collagen (CII) …

NA Staines, N Harper, FJ Ward… - Clinical & …, 1996 - academic.oup.com
The purpose of the study was to map the dominant T cell epitope of the CB11 sequence of
CII in RT1u haplotype rats and to determine if, when used as a synthetic peptide, it would …